0001520138-23-000109.txt : 20230222
0001520138-23-000109.hdr.sgml : 20230222
20230222174739
ACCESSION NUMBER: 0001520138-23-000109
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230216
FILED AS OF DATE: 20230222
DATE AS OF CHANGE: 20230222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MARKHAM PENELOPE
CENTRAL INDEX KEY: 0001770555
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39015
FILM NUMBER: 23654889
MAIL ADDRESS:
STREET 1: C/O BIOVIE, INC
STREET 2: 2120 COLORADO AVENUE, SUITE 230
CITY: SANTA MONICA
STATE: CA
ZIP: 90404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOVIE INC.
CENTRAL INDEX KEY: 0001580149
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462510769
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 680 W NYE LANE
STREET 2: SUITE 201
CITY: CARSON CITY
STATE: NV
ZIP: 89703
BUSINESS PHONE: 775-888-3162
MAIL ADDRESS:
STREET 1: 680 W NYE LANE
STREET 2: SUITE 201
CITY: CARSON CITY
STATE: NV
ZIP: 89703
FORMER COMPANY:
FORMER CONFORMED NAME: NANOANTIBIOTICS, INC.
DATE OF NAME CHANGE: 20130625
4
1
ownership.xml
X0306
4
2023-02-16
0
0001580149
BIOVIE INC.
BIVI
0001770555
MARKHAM PENELOPE
C/O BIOVIE INC.
680 W NYE LANE STE 201
CARSON CITY
NV
89703
0
1
0
0
EVP Liver Cirrhosis R&D
COMMON STOCK
2023-02-16
4
F
0
2476
6.12
D
47841
D
Transaction code F - Payment of tax liability by withholding securities incident to the receipt
/S/ PENELOPE MARKHAM
2023-02-22